NewAmsterdam Pharma (NASDAQ:NAMS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NewAmsterdam Pharma Stock (NASDAQ: NAMS) stock price, news, charts, stock research, profile.

Open	$19.34
Close	$19.91
Volume / Avg.	740.86K / 905.01K
Day Range	$18.88 - $20.13
52 Wk Range	15.19 - 27.29
Market Cap	$2.19B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	3.98%
Days to Cover	3.56

Recent News

Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, STVN.

Lekha Gupta

Top 3 Health Care Stocks That May Collapse This Quarter

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.34
Close	$19.91
Volume / Avg.	740.86K / 905.01K
Day Range	$18.88 - $20.13
52 Wk Range	15.19 - 27.29
Market Cap	$2.19B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	3.98%
Days to Cover	3.56

About NewAmsterdam Pharma Company NV

Sector

Health Care

Industry

Biotechnology

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patien...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NewAmsterdam Pharma (NAMS) stock?

You can purchase shares of NewAmsterdam Pharma (NASDAQ:NAMS) through any online brokerage.

View our list of the best stock brokerages

Who are NewAmsterdam Pharma (NAMS) competitors?

Other companies in NewAmsterdam Pharma’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Mesoblast (NASDAQ:MESO) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for NewAmsterdam Pharma (NAMS) stock?

NewAmsterdam Pharma has a consensus price target of $34.30.

What is the current price for NewAmsterdam Pharma (NAMS)?

The stock price for NewAmsterdam Pharma (NASDAQ: NAMS) is $20.5 last updated February 14, 2025 at 4:16 PM EST.

Does NewAmsterdam Pharma (NAMS) pay a dividend?

There are no upcoming dividends for NewAmsterdam Pharma.

When is NewAmsterdam Pharma (NASDAQ:NAMS) reporting earnings?

NewAmsterdam Pharma’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is NewAmsterdam Pharma (NAMS) going to split?

There is no upcoming split for NewAmsterdam Pharma.

What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

NewAmsterdam Pharma

NewAmsterdam Pharma (NAMS) Forecast